Similar HCV viral load levels and genotype distribution among end-stage renal disease patients on hemodialysis and HCV-infected patients with normal renal function

Journal of Nephrology

Volumn 20, Issue 5, 2007, Pages 609-616

  Azevedo, Henriete A ^a   Villela Nogueira, Cristiane A ^a,d   Perez, Renata M ^a   Segadas Soares, Jorge A ^a   Takahashi, Clarina ^b   Gaburo, Nelson ^c   Pessoa, Isabel ^c   Coelho, Henrique Sérgio M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Renalcor Clinic   (Brazil)

^c Cardiovascular Magnetic Resonance and Computed Tomography Sector   (Brazil)

^d NONE   (Brazil)

Author keywords

ALT; End stage renal disease; Genotype; HCV RNA; Hemodialysis; Hepatitis C; Viral load

Indexed keywords

ALANINE AMINOTRANSFERASE; VIRUS RNA;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; FEMALE; GENOTYPE; GRAFT FAILURE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFECTION RISK; KIDNEY FAILURE; KIDNEY FUNCTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; RISK FACTOR; STATISTICAL SIGNIFICANCE; VIRUS LOAD; BLOOD; BRAZIL; CHRONIC KIDNEY FAILURE; CLINICAL TRIAL; COMPARATIVE STUDY; ENZYMOLOGY; GENETICS; KIDNEY; MIDDLE AGED; MULTICENTER STUDY; RENAL REPLACEMENT THERAPY; VIROLOGY;

ADULT; ALANINE TRANSAMINASE; BRAZIL; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; KIDNEY; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; RENAL DIALYSIS; RNA, VIRAL; VIRAL LOAD;

EID: 38149083228     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Alter MJ, Kruszon-Moran D, Nainan OV, McQuillan GM, Gao F, Moyer LA, Kaslow RA, Margolis HS. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999; 341: 556-62.
2. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001; 345: 41-52.
3. Fabrizi F, Poordad FF, Martin P. Hepatitis C infection and the patient with end-stage renal disease. Hepatology 2002; 36: 3-10.
4. Stehman-Breen CO, Emerson S, Gretch D, Johnson RJ. Risk of death among chronic dialysis patients infected with hepatitis C virus. Am J Kidney Dis 1998; 32: 629-34.
5. Nakayama E, Akiba T, Marumo F, Sato C. Prognosis of antihepatitis C virus antibody-positive patients on regular hemodialysis therapy. J Am Soc Nephrol 2000; 11: 1896-902.
6. Mathurin P, Mouquet C, Poynard T, Sylla, Benalia H, Fretz C, Thibault V, Cadranel JF, Bernard B, Opolon P, Coriat P, Bitker MO. Impact of hepatitis Band C virus on kidney transplantation outcome. Hepatology 1999; 29: 257-83.
7. Forns X, Fernandez-Llama P, Pons M, Costa J, Ampurdanes S, Lopez-Labrador FX, Olmedo E, Lopez-Pedret J, Darnell A, Revert L, Sanchez-Tapias JM, Rodes J. Incidence and risk factors of hepatitis C virus infection in a haemodialysis unit. Nephrol Dial Transplant 1997; 12: 736-40.
8. Cheney CP, Chopra S, Graham C. Hepatitis C. Infect Dis Clin North Am 2000; 14: 633-67.
9. Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Vinson S, Mousa M, Gitnick G. Biological dynamics of viral load in hemodialysis patients with hepatitis C virus. Am J Kidney Dis 2000; 35: 122-9.
10. Carneiro MA, Teles SA, Dias MA, Ferreira RC, Naghettine AV, Silva SA, Lampe E, Yoshida CF, Martins RM. Decline of hepatitis C infection in hemodialysis patients in Central Brazil: A ten years of surveillance. Mem Inst Oswaldo Cruz 2005; 100: 345-9.
11. Sypsa V, Psichogiou M, Katsoulidou A, Skoutelis G, Moutafis S, Hadjiconstantinou V, Kakavas J, Kalapothaki V, Boletis J, Hatzakis A. Incidence and patterns of hepatitis C virus seroconversion in a cohort of hemodialysis patients. Am J Kidney Dis 2005; 45: 334-43.
12. Umlauff F, Gruenewald K, Weiss G, Kessler H, Urbanek M, Haun M, Santner B, Koenig P, Keeffe EB. Patterns of hepatitis C viremia in patients receiving hemodialysis. Am J Gastroenterol 1997; 92: 73-8.
13. Sterling RK, Sanyal AJ, Luketic VA, Stravitz RT, King AL, Post AB, Mills AS, Contos MJ, Shiffman ML. Chronic hepatitis C infection in patients with end stage renal disease: characterization of liver histology and viral load in patients awaiting renal transplantation. Am J Gastroenterol 1999; 94: 3576-82.
14. Furusyo N, Hayashi J, Ariyama I, Sawayama Y, Etoh Y, Shigematsu M, Kashiwagi S. Maintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infection. Am J Gastroenterol 2000; 95: 4906.
15. Cotler SJ, Diaz G, Gundlapalli S, Jakate S, Chawla A, Mital D, Jensik S, Jensen DM. Characteristics of hepatitis C in renal transplant candidates. J Clin Gastroenterol 2002; 35: 191-5.
16. Fabrizi F, Bunnapradist S, Lunghi G, Martin P. Kinetics of hepatitis C virus load during hemodialysis: Novel perspectives. J Nephrol 2003; 16: 467-75.
17. Hinrichsen H, Leimenstoll G, Stegen G, Schrader H, Folsch UR, Schmidt WE. Prevalence and risk factors of hepatitis C virus infection in haemodialysis patients: A multicentre study in 2796 patients. Gut 2002; 51: 429-33.
18. Oliveira ML, Bastos FI, Sabino RR, Paetzold U, Schreier E, Pauli G, Yoshida CF. Distribution of HCV genotypes among different exposure categories in Brazil. Braz J Med Biol Res 1999; 32: 279-82.
19. Perez RM, Ferraz ML, Figueiredo MS, Contado D, Koide S, Ferreira AP, Cendoroglo Neto M, Medina Pestana JO, Silva AE. Unexpected distribution of hepatitis C virus genotypes in patients on hemodialysis and kidney transplant recipients. J Med Virol 2003; 69: 489-94.
20. Espinosa M, Martin-Malo A, Alvarez de Lara MA, Aljama R Risk of death and liver cirrhosis in anti-HCV-positive longterm haemodialysis patients. Nephrol Dial Transplant 2001; 16: 1669-74.
21. Bailey GL, Katz Al, Hampers CL, Merrill JP. Alterations in serum enzymes in chronic renal failure. JAMA 1970; 213: 2263-5.
22. Guh JY, Lai YH, Yang CY, Chen SC, Chuang WL, Hsu TC, Chen HC, Chang WY, Tsai JH. Impact of decreased serum transaminase levels on the evaluation of viral hepatitis in hemodialysis patients. Nephron 1995; 69: 459-65.
23. Yasuda K, Okuda K, Endo N, Ishiwatari Y, Ikeda R, Hayashi H, Yokozeki K, Kobayashi S, Irie Y. Hypoaminotransferasemia in patients undergoing long-term hemodialysis: clinical and biochemical appraisal. Gastroenterology 1995; 109: 1295-300.
24. Espinosa M, Martin-Malo A, Alvarez de Lara MA, Soriano S, Aljama P. High ALT levels predict viremia in anti-HCV-positive HD patients if a modified normal range of ALT is applied. Clin Nephrol 2000; 54: 151-6.
25. Pol S, Romeo R, Zins B, Driss F, Lebkiri B, Carnot F, Berthelot P, Brechot C. Hepatitis C virus RNA in anti-HCV positive hemodialyzed patients: Significance and therapeutic implications. Kidney Int 1993; 44: 1097-100.
26. Glicklich D, Thung SN, Kapoian T, Tellis V, Reinus JF. Comparison of clinical features and liver histology in hepatitis C-positive dialysis patients and renal transplant recipients. Am J Gastroenterol 1999; 94: 159-63.
27. Yuki N, Ishida H, Inoue T, Tabata T, Matsushita Y, Kishimoto H, Kato M, Masuzawa M, Sasaki Y, Hayashi N, Hori M. Reappraisal of biochemical hepatitis C activity in hemodialysis patients. J Clin Gastroenterol 2000; 30: 187-94.
28. Fabrizi F, Lunghi G, Finazzi S, Colucci P, Pagano A, Ponticelli C, Locatelli F. Decreased serum aminotransferase activity in patients with chronic renal failure: Impact on the detection of viral hepatitis. Am J Kidney Dis 2001; 38: 1009-15.
29. Saab S, Brezina M, Gitnick G, Martin P, Yee HF Jr. Hepatitis C screening strategies in hemodialysis patients. Am J Kidney Dis 2001; 38: 91-7.
30. Hung KY, Lee KC, Yen CJ, Wu KD, Tsai TJ, Chen WY. Revised cutoff values of serum aminotransferase in detecting viral hepatitis among CAPD patients: Experience from Taiwan, an endemic area for hepatitis B. Nephrol Dial Transplant 1997; 12: 180-3.
31. Gouveia EC, Lopes EP, Moura I, Cruz M, Kosminsky L, Pernambuco JR. Identification of the cutoff value for serum alanine aminotransferase in hepatitis C screening of patients with chronic renal failure on hemodialysis. Rev Soc Bras Med Trop 2004; 37: 18-21.
32. Fabrizi F, Martin P, Dixit V, Brezina M, Cole MJ, Gerosa S, Vinson S, Mousa M, Gitnick G. Quantitative assessment of HCV load in chronic hemodialysis patients: A cross-sectional survey. Nephron 1998; 80: 428-33.
33. Angelico M, Morosetti M, Passalacqua S, Chiappini MG, Botta S, Ombres D, Splendiani G, Casciani CU. Low levels of hepatitis C virus RNA in blood of infected patients under maintenance haemodialysis with high-biocompatibility, high-permeability filters. Dig Liver Dis 2000; 32: 724-8.
34. Okuda K, Hayashi H, Yokozeki K, Irie Y. Destruction of hepatitis C virus particles by haemodialysis. Lancet 1996; 347: 909-10.
35. Wang T, Wang TH, Shen JC, Lin SM, Chen DS. Effects of anticoagulants and storage of blood samples on efficacy of the polymerase chain reaction assay for hepatitis C virus. J Chem Microbiol 1992; 30: 750-3.
36. Mizuno M, Higuchi T, Yanai M, Kanmatsuse K, Esumi M. Dialysis-membrane-dependent reduction and adsorption of circulating hepatitis C virus during hemodialysis. Nephron 2002; 91: 235-42.
37. Badalamenti S, Catania A, Lunghi G, Covini G, Bredi E, Brancaccio D, Salvadori M, Como G, Ponticelli C, Graziani G. Changes in viremia and circulating interferon-alpha during hemodialysis in hepatitis C virus-positive patients: Only coincidental phenomena? Am J Kidney Dis 2003; 42: 143-50.
38. Chan TM, Lok AS, Cheng IK, Chan RT. Prevalence of hepatitis C virus infection in hemodialysis patients: A longitudinal study comparing the results of RNA and antibody assays. Hepatology 1993; 17: 5-8.
39. Bouchardeau F, Chauveau P, Courouce AM, Poignet JL. Genotype distribution and transmission of hepatitis C virus (HCV) in French haemodialysed patients. Nephrol Dial Transplant 1995; 10: 2250-2.
40. Colleoni N, Bucci R, Ribero ML, Zhou J, D'Amico G, Tagger A. Hepatitis C virus genotype in anti-HCV-positive hemodialysed patients. Nephrol Dial Transplant 1996; 11: 2258-64.
41. Goessens C, Jadoul M, Walon C, Burtonboy G, Cornu C. Hepatitis C virus genotypes in hemodialyzed patients: A multicentric study. Clin Nephrol 1997; 47: 367-71.
42. Busek SU, Baba EH, Tavares Filho HA, Pimenta L, Salomao A, Correa-Oliveira R, Oliveira GC. Hepatitis C and hepatitis B virus infection in different hemodialysis units in Belo Horizonte, Minas Gerais, Brazil. Mem Inst Oswaldo Cruz 2002; 97: 775-8.
43. Souza KP, Luz JA, Teles SA, Carneiro MA, Oliveira LA, Gomes AS, Dias MA, Gomes SA, Yoshida CF, Martins RM. Hepatitis Band C in the hemodialysis unit of Tocantins, Brazil: Serological and molecular profiles. Mem Inst Oswaldo Cruz 2003; 98: 599-603.
44. Okamoto H, Mishiro S, Tokita H, Tsuda F, Miyakawa Y, Mayumi M. Superinfection of chimpanzees carrying hepatitis C virus of genotype II/ 1b with that of genotype III/2a or I/1a. Hepatology 1994; 20: 1131-6.
45. Qian KP, Natov SN, Pereira BJ, Lau JY. Hepatitis C virus mixed genotype infection in patients on haemodialysis. J Viral Hepat 2000; 7: 153-60.